A pharmacokinetic and tolerability study of fexinidazole in a single oral dose in adult participants with mild and moderate hepatic impairment

Trial Identifier:	POP17145
Sponsor:	Sanofi
Start Date:	January 2023
Primary Completion Date:	May 2023
Study Completion Date:	May 2023
Condition:	Liver, Pancreas & Gallbladder - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Bulgaria	Sofia, Bulgaria, 1612
France	Rennes, France

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.